ASMB Assembly Biosciences, Inc. - Common Stock
$32,87
Prezzo · Ago 19, 2026
Fondamentali al Ago 13, 2026
Intervallo 52 sett.
$20–$40
65% of range
Rating Analisti
BUY
10 analysts
Prezzo Obiettivo
$50
+52% upside
P/E (TTM)
-59.8
ROE
-5.5%
Margine di Profitto Netto
-8.5%
ASMB Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$32.87
Capitalizzazione di Mercato
$521M
P/E (TTM)
-59.8
EPS (TTM)
$-0.55
Ricavi (TTM)
$72M
Rendimento div.
—
ROE
-5.5%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$20 – $40
ASMB Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$72M
2016-12-31
→
2025-12-31
EPS
$-0.55
2021-12-31
→
2025-12-31
Flusso di cassa libero
$-41M
2016-12-31
→
2025-12-31
Margini
-8.5%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
ASMB
Mediana dei peer
P/E (TTM)
-59.8
19.6
P/S (TTM)
7.2
6.4
P/B
2.5
2.6
Price / FCF (Prezzo / FCF)
-12.7
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
ASMB
Mediana dei peer
Operating Margin (Margine Operativo)
-16.8%
—
Net Profit Margin (Margine di Profitto Netto)
-8.5%
-104.2%
ROA
-3.2%
-40.3%
ROE
-5.5%
-42.4%
ROIC
-5.9%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
ASMB
Mediana dei peer
Current Ratio (Rapporto corrente)
5.2
5.4
Quick Ratio
1.2
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
ASMB
Mediana dei peer
Revenue YoY (Ricavi YoY)
153.5%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
65.8%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
-1.8%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
ASMB
Mediana dei peer
ASMB Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
10 analisti
- Acquisto forte 4 40,0%
- Compra 5 50,0%
- Mantieni 1 10,0%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
4 analisti · 2026-08-16
Mediana
$47.50
Media
$50.00
← Sotto tutti i target
$32.87
Basso
$43.00
Alto
$62.00
Target mediano
$47.50
+44,5%
Target medio
$50.00
+52,1%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.71%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $-0.54 | $-0.58 | 0.04% |
| 31 Dicembre 2025 | $2.48 | $-0.66 | 3.1% |
| 30 Settembre 2025 | $-0.72 | $-0.79 | 0.07% |
| 30 Giugno 2025 | $-1.33 | $-1.39 | 0.06% |
| 31 Marzo 2025 | $-1.17 | $-1.63 | 0.46% |
| 31 Dicembre 2024 | $-1.57 | $-2.08 | 0.51% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| EIKN | — | — | — | — | — | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $29M | $7M | $0 | $6M | $79M | $16M | $15M | $9M | $0 | |
| R&D Expense | $65M | $56M | $49M | $70M | $69M | $107M | $86M | $73M | $44M | $33M | |
| SG&A Expense | $20M | $18M | $23M | $24M | $29M | $37M | $33M | $35M | $17M | $12M | |
| Operating Expenses | $84M | $74M | $72M | $94M | $139M | $144M | $119M | $108M | $61M | · | |
| Operating Income | $-12M | $-45M | $-65M | $-94M | $-133M | $-65M | $-103M | $-93M | $-52M | $-45M | |
| Other Non-op | $6M | $6M | $3M | $1M | $302.0K | $3M | $4M | $3M | $368.0K | $399.0K | |
| Pretax Income | $-6M | $-40M | $-61M | $-93M | $-132M | $-62M | $-98M | $-90M | $-52M | $-45M | |
| Income Tax | $0 | $330.0K | $33.0K | $0 | $-3M | $0 | $-774.0K | $1M | $-9M | $-618.0K | |
| Net Income | $-6M | $-40M | $-61M | $-93M | $-130M | $-62M | $-98M | $-91M | $-43M | $-44M | |
| EPS (Basic) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | · | · | · | · | · | |
| EPS (Diluted) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | · | · | · | · | · | |
| Shares (Basic) | 11,210,934 | 6,004,560 | 4,577,371 | 4,034,105 | 43,280,383 | · | · | · | · | · | |
| Shares (Diluted) | 11,210,934 | 6,004,560 | 4,577,371 | 4,034,105 | 43,280,383 | · | · | · | · | · | |
| EBITDA | $-12M | $-45M | $-64M | $-94M | $-132M | $-64M | $-102M | $-93M | $-52M | $-45M |
Stato Patrimoniale 25
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $38M | $20M | $52M | $46M | $59M | $47M | $41M | $82M | $29M | |
| Short-term Investments | · | · | · | · | · | · | · | $177M | $38M | $24M | |
| Receivables | $974.0K | $0 | $43.0K | $944.0K | $336.0K | $1M | $3M | $2M | $2M | $0 | |
| Prepaid Expense | $5M | $3M | $3M | $4M | $7M | $7M | $5M | $2M | $898.0K | $611.2K | |
| Current Assets | $255M | $116M | $134M | $97M | $154M | $224M | $283M | $223M | $123M | $54M | |
| PP&E (Net) | $221.0K | $284.0K | $385.0K | $743.0K | $1M | $2M | $2M | $557.0K | $860.0K | $214.7K | |
| PP&E (Gross) | · | · | $595.0K | $2M | $2M | $3M | $3M | $1M | $1M | $409.3K | |
| Accum. Depreciation | · | · | $210.0K | $2M | $1M | $2M | $1M | $1M | $414.0K | $194.6K | |
| Goodwill | · | · | · | · | · | $13M | $13M | $13M | $13M | $13M | |
| Intangibles | · | · | · | · | · | · | · | · | $29M | $29M | |
| Other Non-current Assets | $312.0K | $312.0K | $312.0K | $889.0K | $2M | $6M | $2M | $3M | $340.0K | · | |
| Total Assets | $258M | $119M | $137M | $102M | $191M | $283M | $340M | $268M | $169M | $98M | |
| Accounts Payable | $1M | $585.0K | $461.0K | $2M | $3M | $5M | $2M | $4M | · | · | |
| Accrued Liabilities | $8M | $7M | $6M | $7M | $7M | $12M | $8M | $10M | $6M | $5M | |
| Current Liabilities | $49M | $48M | $39M | $16M | $16M | $24M | $24M | $18M | $13M | $7M | |
| Capital Leases | $2M | $3M | $1M | $101.0K | $3M | $7M | $9M | $0 | · | · | |
| Deferred Tax | · | · | · | · | · | $3M | $3M | $3M | · | · | |
| Total Liabilities | $51M | $86M | $96M | $19M | $22M | $43M | $67M | $57M | $56M | $18M | |
| Common Stock | $16.0K | $7.0K | $5.0K | $4.0K | $48.0K | $34.0K | $32.0K | $25.0K | $20.0K | $17.2K | |
| Paid-in Capital | · | · | · | · | · | · | · | $553M | $365M | $289M | |
| Retained Earnings | $-832M | $-826M | $-786M | $-725M | $-631M | $-502M | $-439M | $-342M | $-251M | $-208M | |
| AOCI | $-41.0K | $-211.0K | $-81.0K | $-803.0K | $-419.0K | $-270.0K | $-201.0K | $-347.0K | $-392.0K | $-600.8K | |
| Stockholders' Equity | $207M | $33M | $41M | $83M | $169M | $241M | $273M | $211M | $113M | $80M | |
| Liabilities + Equity | $258M | $119M | $137M | $102M | $191M | $283M | $340M | $268M | $169M | $98M | |
| Shares Outstanding | 15,855,329 | 7,457,240 | 5,482,752 | 4,074,552 | 48,120,437 | 34,026,680 | 32,558,307 | 25,495,425 | 20,137,974 | 17,246,754 |
Flusso di cassa 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $129.0K | $129.0K | $450.0K | $498.0K | $466.0K | $691.0K | $494.0K | $643.0K | $219.0K | · | |
| Stock-based Comp | $5M | $3M | $5M | $7M | $5M | $22M | $21M | $28M | $9M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | $-3M | $0 | $-774.0K | $1M | $-9M | $-618.0K | |
| Restructuring | · | · | $0 | $1M | $2M | $4M | $2M | · | · | · | |
| Other Non-cash | $-40M | $-14M | $78M | $2M | $33M | $-23M | $-7M | · | · | · | |
| Operating Cash Flow | $-41M | $-51M | $23M | $-84M | $-93M | $-63M | $-84M | $-65M | $2M | $-35M | |
| CapEx | $66.0K | $28.0K | $255.0K | $102.0K | $3M | $470.0K | $2M | $340.0K | $865.0K | $147.0K | |
| Investing Cash Flow | $-113M | $40M | $-69M | $91M | $27M | $68M | $-50M | $-135M | $-16M | $36M | |
| Stock Issued | $2M | $2M | $5M | $325.0K | $53M | $5M | $135M | $155M | $65M | · | |
| Net Stock Activity | $2M | $2M | $5M | $325.0K | $53M | $5M | $135M | · | · | · | |
| Financing Cash Flow | $175M | $29M | $14M | $614.0K | $53M | $8M | $140M | $160M | $67M | $153.0K | |
| Net Change in Cash | $20M | $19M | $-33M | $7M | $-14M | $13M | $5M | $-41M | $53M | $1M | |
| Taxes Paid | · | $400.0K | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-41M | $-51M | $22M | $-85M | $-96M | $-63M | $-86M | $-65M | $995.5K | $-35M |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -16.8% | -159.3% | -902.5% | · | -2121.7% | -81.9% | -643.4% | -626.4% | · | · | |
| Net Margin | -8.5% | -140.9% | -854.8% | · | -2076.3% | -78.6% | -611.6% | -613.0% | · | · | |
| Pretax Margin | -8.5% | -139.7% | -854.3% | · | -2116.8% | -78.6% | -616.5% | -605.6% | · | · | |
| EBITDA Margin | -16.6% | -158.8% | -896.2% | · | -2114.2% | -81.0% | -640.4% | -626.4% | · | · | |
| ROA | -3.2% | -31.4% | -51.3% | -63.6% | -54.8% | -20.0% | -32.1% | -41.5% | -32.0% | -38.2% | |
| ROE | -5.5% | -135.4% | -147.9% | -100.6% | -66.0% | -24.3% | -45.4% | -41.2% | -44.4% | -44.6% | |
| ROIC | -5.9% | -137.3% | -157.4% | -113.9% | -77.0% | · | -37.3% | -44.6% | -38.1% | -55.9% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 2.4 | 3.4 | 6.0 | 9.6 | 9.2 | 11.6 | 12.0 | 9.1 | 7.5 | |
| Quick Ratio | 1.2 | 0.8 | 0.5 | 3.3 | 2.9 | 2.5 | 2.1 | 11.9 | 9.1 | 7.4 |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | 0.1 | · | 0.0 | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 148.5 | 1326.5 | 14.5 | · | 8.0 | 34.4 | 5.5 | 6.3 | · | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 153.5% | 298.2% | · | · | -92.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 65.8% | -55.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $72M | $29M | $7M | $0 | $6M | $79M | $16M | $15M | $9M | $0 | |
| Net Income TTM | $-6M | $-40M | $-61M | $-93M | $-130M | $-62M | $-98M | $-91M | $-43M | $-44M | |
| Market Cap | $539M | $118M | $54M | $763M | $1.35B | $2.47B | $7.99B | $6.92B | $10.93B | $2.51B | |
| P/E | -61.8 | -2.4 | -0.7 | -0.7 | -9.3 | -41.0 | -68.2 | · | · | · | |
| P/S | 7.5 | 4.1 | 7.5 | · | 215.1 | 31.2 | 500.8 | 467.5 | 1212.4 | · | |
| P/B | 2.6 | 3.5 | 1.3 | 9.2 | 8.0 | 10.3 | 29.3 | 32.9 | 96.7 | 31.5 | |
| P / Tangible Book | 2.6 | 3.5 | 1.3 | 9.2 | 8.0 | 10.8 | · | · | · | · | |
| P / Cash Flow | -13.1 | -2.3 | 2.4 | -9.0 | -14.4 | -39.2 | -95.1 | -106.5 | 5878.7 | -72.1 | |
| P / FCF | -13.1 | -2.3 | 2.4 | -9.0 | -13.9 | -38.9 | -93.4 | -106.0 | 10984.2 | -71.8 | |
| Earnings Yield | -1.6% | -42.4% | -136.0% | -148.0% | -10.7% | -2.4% | -1.5% | · | · | · |
Conto Economico 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13M | $8M | $42M | $11M | $10M | $9M | $7M | $7M | $9M | $6M | $7M | $0 | $0 | $0 | · | · | |
| R&D Expense | $15M | $15M | $17M | $17M | $16M | $15M | $14M | $14M | $16M | $12M | $11M | $11M | $13M | $15M | $17M | $18M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $9M | $4M | $5M | $5M | $6M | $5M | |
| Operating Expenses | $20M | $20M | $23M | $22M | $21M | $19M | $19M | $18M | $21M | $17M | $20M | $15M | $17M | $20M | $23M | $23M | |
| Operating Income | $-6M | $-11M | $20M | $-11M | $-11M | $-10M | $-12M | $-11M | $-12M | $-11M | $-13M | $-15M | $-17M | $-20M | $-23M | $-23M | |
| Other Non-op | $2M | $2M | $2M | $2M | $895.0K | $1M | $1M | $1M | $1M | $2M | $2M | $628.0K | $592.0K | $609.0K | $583.0K | $256.0K | |
| Pretax Income | · | · | $22M | $-9M | $-10M | · | $-10M | $-10M | $-11M | · | $-11M | $-14M | $-17M | · | · | · | |
| Income Tax | · | · | $0 | $0 | $0 | · | $-76.0K | $0 | $406.0K | · | $33.0K | $0 | $0 | · | · | · | |
| Net Income | $-4M | $-9M | $22M | $-9M | $-10M | $-9M | $-10M | $-10M | $-11M | $-9M | $-11M | $-14M | $-17M | $-19M | $-22M | $-23M | |
| EPS (Basic) | $-0.20 | $-0.54 | $2.67 | $-0.72 | $-1.33 | $-1.17 | $-1.54 | $-1.51 | $-1.98 | $-1.66 | $-1.75 | $-3.29 | $-3.88 | $-4.46 | $-21.61 | $-0.48 | |
| EPS (Diluted) | $-0.20 | $-0.54 | $2.67 | $-0.72 | $-1.33 | $-1.17 | $-1.54 | $-1.51 | $-1.98 | $-1.66 | $-1.75 | $-3.29 | $-3.88 | $-4.46 | $-21.61 | $-0.48 | |
| Shares (Basic) | 18,853,646 | 16,900,232 | -16,637,363 | 12,686,122 | 7,655,854 | 7,506,321 | -11,472,936 | 6,351,431 | 5,642,752 | 5,483,313 | -8,409,117 | 4,380,444 | 4,355,007 | 4,251,037 | -140,831,719 | 48,448,399 | |
| Shares (Diluted) | 18,853,646 | 16,900,232 | -16,637,363 | 12,686,122 | 7,655,854 | 7,506,321 | -11,472,936 | 6,351,431 | 5,642,752 | 5,483,313 | -8,409,117 | 4,380,444 | 4,355,007 | 4,251,037 | -140,831,719 | 48,448,399 | |
| EBITDA | $-6M | $-11M | · | $-11M | $-11M | $-10M | · | $-11M | $-12M | $-11M | · | $-15M | $-17M | $-19M | · | $-23M |
Stato Patrimoniale 20
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $31M | $58M | $23M | $24M | $23M | $38M | $28M | $19M | $19M | $20M | $27M | $22M | $43M | $52M | $55M | |
| Receivables | $822.0K | $451.0K | $974.0K | $912.0K | · | · | $0 | $0 | $0 | $43.0K | $43.0K | $0 | $342.0K | $717.0K | $944.0K | $1M | |
| Prepaid Expense | $7M | $6M | $5M | $3M | $2M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $6M | $4M | $5M | |
| Current Assets | $328M | $233M | $255M | $237M | $77M | $96M | $116M | $98M | $113M | $117M | $134M | $50M | $64M | $80M | $97M | $115M | |
| PP&E (Net) | $315.0K | $214.0K | $221.0K | $229.0K | $219.0K | $251.0K | $284.0K | $316.0K | $349.0K | $367.0K | $385.0K | $561.0K | $541.0K | $619.0K | $743.0K | $867.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Other Non-current Assets | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $552.0K | $332.0K | $334.0K | $889.0K | $2M | |
| Total Assets | $331M | $236M | $258M | $240M | $81M | $99M | $119M | $100M | $115M | $120M | $137M | $52M | $67M | $83M | $102M | $122M | |
| Accounts Payable | $1M | $1M | $1M | $2M | $743.0K | $875.0K | $585.0K | $1M | $801.0K | $727.0K | $461.0K | $758.0K | $904.0K | $1M | $2M | $2M | |
| Accrued Liabilities | $3M | $3M | $8M | $6M | $3M | $2M | $7M | $5M | $4M | $2M | $6M | $4M | $4M | $3M | $7M | $6M | |
| Current Liabilities | $23M | $35M | $49M | $53M | $47M | $47M | $48M | $42M | $41M | $39M | $39M | $7M | $9M | $10M | $16M | $15M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $113.0K | $451.0K | $791.0K | $1M | $50.0K | $64.0K | $80.0K | $101.0K | $918.0K | |
| Total Liabilities | $25M | $37M | $51M | $57M | $63M | $72M | $86M | $74M | $81M | $87M | $96M | $10M | $12M | $13M | $19M | $19M | |
| Common Stock | $20.0K | $16.0K | $16.0K | $16.0K | $8.0K | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $53.0K | $52.0K | $52.0K | $4.0K | $48.0K | |
| Retained Earnings | $-845M | $-841M | $-832M | $-854M | $-845M | $-835M | $-826M | $-816M | $-806M | $-795M | $-786M | $-775M | $-760M | $-743M | $-725M | $-702M | |
| AOCI | $-623.0K | $-368.0K | $-41.0K | $-90.0K | $-279.0K | $-253.0K | $-211.0K | $-156.0K | $-293.0K | $-239.0K | $-81.0K | $-275.0K | $-325.0K | $-513.0K | $-803.0K | $-999.0K | |
| Stockholders' Equity | $306M | $199M | $207M | $183M | $18M | $27M | $33M | $26M | $35M | $33M | $41M | $42M | $55M | $70M | $83M | $102M | |
| Liabilities + Equity | $331M | $236M | $258M | $240M | $81M | $99M | $119M | $100M | $115M | $120M | $137M | $52M | $67M | $83M | $102M | $122M | |
| Shares Outstanding | 19,850,342 | 15,892,353 | 15,855,329 | 15,816,987 | 7,672,249 | 7,618,885 | 7,457,240 | 6,354,414 | 6,345,561 | 5,482,752 | 5,482,752 | 52,614,194 | 52,450,731 | 52,015,268 | 4,074,552 | 48,481,194 |
Flusso di cassa 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20.0K | $26.0K | $32.0K | $32.0K | $32.0K | $33.0K | $32.0K | $33.0K | $32.0K | $32.0K | $84.0K | $116.0K | $126.0K | $124.0K | $124.0K | $134.0K | |
| Stock-based Comp | $2M | $1M | $1M | $2M | $834.0K | $712.0K | $751.0K | $797.0K | $833.0K | $739.0K | $959.0K | $1M | $1M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-700.0K | $800.0K | |
| Other Non-cash | · | $-14M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $14M | $-15M | $-17M | $-23M | $-407.0K | $-15M | $-17M | $-18M | $74M | $-14M | $-14M | $-23M | $-19M | $-20M | |
| CapEx | $0 | $19.0K | $24.0K | $42.0K | $0 | $0 | $0 | $0 | $14.0K | $14.0K | $71.0K | $136.0K | $48.0K | $0 | $0 | $102.0K | |
| Investing Cash Flow | $-92M | $-5M | $21M | $-158M | $17M | $7M | $-7M | $24M | $5M | $17M | $-90M | $19M | $-8M | $10M | $17M | $31M | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $2M | $2M | $0 | $0 | $0 | $0 | $0 | $54.0K | $4M | $325.0K | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $2M | · | · | · | $0 | · | · | · | $4M | · | · | |
| Financing Cash Flow | $109M | $149.0K | $456.0K | $172M | $357.0K | $2M | $17M | $0 | $12M | $0 | $9M | $0 | $134.0K | $4M | $437.0K | $0 | |
| Net Change in Cash | $1M | $-27M | $36M | $-1M | $593.0K | $-15M | $10M | $9M | $459.0K | $-1M | $-7M | $5M | $-22M | $-9M | $-2M | $12M | |
| Free Cash Flow | · | $-22M | · | · | · | $-23M | · | · | · | $-18M | · | · | · | · | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -47.4% | -138.4% | · | -100.9% | -115.2% | -105.5% | · | -160.1% | -143.0% | -185.5% | · | · | · | · | · | · | |
| Net Margin | -28.8% | -110.5% | · | -85.2% | -105.9% | -93.6% | · | -140.4% | -130.7% | -156.9% | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | -85.2% | -105.9% | · | · | -140.4% | -125.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -47.4% | -138.1% | · | -100.9% | -115.2% | -105.2% | · | -160.1% | -143.0% | -184.9% | · | · | · | · | · | · | |
| ROA | -1.9% | -5.4% | · | -5.4% | -10.4% | -8.1% | · | -12.7% | -12.3% | -8.9% | · | -16.7% | -16.1% | -15.4% | · | -12.5% | |
| ROE | -2.4% | -8.0% | · | -8.8% | -38.6% | -29.5% | · | -28.4% | -24.9% | -17.6% | · | -20.0% | -18.9% | -17.5% | · | -14.1% | |
| ROIC | · | · | · | -6.0% | -61.3% | · | · | -42.1% | -36.5% | · | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.0 | 6.6 | · | 4.4 | 1.6 | 2.0 | · | 2.4 | 2.7 | 3.0 | · | 7.0 | 7.3 | 8.0 | · | 7.4 | |
| Quick Ratio | 1.4 | 0.9 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.5 | 0.5 | · | 3.7 | 2.5 | 4.4 | · | 3.6 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | · | · | |
| Receivables Turnover | 32.5 | 33.3 | · | 23.7 | · | · | · | · | 49.9 | 15.2 | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42M | $38M | · | $37M | $34M | $31M | · | $21M | $14M | $6M | · | · | · | · | · | · | |
| Net Income TTM | $-32M | $-37M | · | $-38M | $-40M | $-39M | · | $-44M | $-52M | $-59M | · | $-73M | $-83M | $-90M | · | $-90M | |
| Market Cap | $545M | $441M | · | $405M | $139M | $73M | · | $96M | $87M | $73M | · | $562M | $724M | $524M | · | $954M | |
| P/E | -9.8 | -7.4 | · | -5.4 | -3.0 | -1.5 | · | -1.8 | -1.3 | -1.0 | · | -0.9 | -1.5 | -1.7 | · | -10.5 | |
| P/S | 13.0 | 11.6 | · | 11.0 | 4.0 | 2.4 | · | 4.5 | 6.1 | 12.6 | · | · | · | · | · | · | |
| P/B | 1.8 | 2.2 | · | 2.2 | 7.7 | 2.7 | · | 3.7 | 2.5 | 2.2 | · | 13.5 | 13.2 | 7.5 | · | 9.3 | |
| P / Tangible Book | 1.8 | 2.2 | · | 2.2 | 7.7 | 2.7 | · | 3.7 | 2.5 | 2.2 | · | 13.5 | 13.2 | 7.5 | · | 9.3 | |
| P / Cash Flow | · | -20.0 | · | · | · | -3.1 | · | · | · | -4.0 | · | · | · | -22.4 | · | · | |
| P / FCF | · | -19.9 | · | · | · | -3.1 | · | · | · | -4.0 | · | · | · | · | · | · | |
| Earnings Yield | -10.2% | -13.6% | · | -18.5% | -33.1% | -66.1% | · | -55.8% | -78.8% | -99.9% | · | -113.4% | -67.6% | -58.8% | · | -9.6% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $72M | $29M | $7M | $0 | $6M |
| Margine Operativo % | -16.8% | -159.3% | -902.5% | — | -2121.7% |
| Utile netto | $-6M | $-40M | $-61M | $-93M | $-130M |
| EPS Diluito | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 5.2 | 2.4 | 3.4 | 6.0 | 9.6 |
| Quick Ratio | 1.2 | 0.8 | 0.5 | 3.3 | 2.9 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-41M | $-51M | $22M | $-85M | $-96M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 98 filer · $481.1M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 40 (+27 vs trimestre precedente) | 13 (+4 vs trimestre precedente) | 29 (0 vs trimestre precedente) | 18 (+4 vs trimestre precedente) | +5.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | $136.770.406 | 4.977.089 | 28,43% | Azioni |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $44.094.133 | 1.604.590 | 9,17% | Azioni |
| Paradigm Biocapital Advisors LP | $42.696.995 | 1.553.748 | 8,88% | Azioni |
| Commodore Capital LP | $38.884.200 | 1.415.000 | 8,08% | Azioni |
| RA CAPITAL MANAGEMENT, L.P. | $28.040.867 | 1.020.410 | 5,83% | Azioni |
| JANUS HENDERSON GROUP PLC | $23.479.147 | 849.309 | 4,88% | Azioni |
| Parkman Healthcare Partners LLC | $19.818.054 | 721.181 | 4,12% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.359.726 | 558.942 | 3,19% | Azioni |
| Point72 Asset Management, L.P. | $12.657.096 | 460.593 | 2,63% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $8.211.216 | 298.807 | 1,71% | Azioni |
| Schonfeld Strategic Advisors LLC | $6.654.363 | 242.153 | 1,38% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $6.595.964 | 239.963 | 1,37% | Azioni |
| AMERIPRISE FINANCIAL INC | $6.320.400 | 230.000 | 1,31% | Azioni |
| DV EQUITIES, LLC | $6.221.884 | 226.415 | 1,29% | Azioni |
| Aberdeen Group plc | $5.689.652 | 207.047 | 1,18% | Azioni |
| Seven Fleet Capital Management LP | $5.680.995 | 206.732 | 1,18% | Azioni |
| Affinity Asset Advisors, LLC | $5.221.200 | 190.000 | 1,09% | Azioni |
| B Group, Inc. | $4.828.401 | 175.706 | 1,00% | Azioni |
| STATE STREET CORP | $4.724.664 | 171.931 | 0,98% | Azioni |
| STEMPOINT CAPITAL LP | $4.681.987 | 170.378 | 0,97% | Azioni |
| Squadron Capital Management LLC | $4.396.800 | 160.000 | 0,91% | Azioni |
| Woodline Partners LP | $4.143.434 | 150.780 | 0,86% | Azioni |
| Driehaus Capital Management LLC | $4.122.000 | 150.000 | 0,86% | Azioni |
| Ally Bridge Group (NY) LLC | $3.847.200 | 140.000 | 0,80% | Azioni |
| GOLDMAN SACHS GROUP INC | $3.359.155 | 122.240 | 0,70% | Azioni |
| FRANKLIN RESOURCES INC | $3.110.736 | 113.200 | 0,65% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.504.884 | 91.153 | 0,52% | Azioni |
| VANGUARD GROUP INC | $2.269.895 | 66.742 | 0,47% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $2.032.696 | 73.970 | 0,42% | Azioni |
| HighVista Strategies LLC | $2.017.170 | 73.405 | 0,42% | Azioni |
| Qube Research & Technologies Ltd | $1.414.890 | 51.488 | 0,29% | Azioni |
| MONIMUS CAPITAL MANAGEMENT, LP | $1.307.498 | 47.580 | 0,27% | Azioni |
| Trexquant Investment LP | $1.254.764 | 45.661 | 0,26% | Azioni |
| XTX Topco Ltd | $1.179.387 | 42.918 | 0,25% | Azioni |
| JPMORGAN CHASE & CO | $1.126.389 | 41.780 | 0,23% | Azioni |
| MORGAN STANLEY | $1.116.705 | 40.637 | 0,23% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.083.839 | 39.441 | 0,23% | Azioni |
| BlackRock, Inc. | $980.926 | 35.696 | 0,20% | Azioni |
| Squarepoint Ops LLC | $940.201 | 34.214 | 0,20% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $800.437 | 29.128 | 0,17% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $665.098 | 24.203 | 0,14% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $653.062 | 23.765 | 0,14% | Azioni |
| Caption Management, LLC | $627.341 | 22.829 | 0,13% | Azioni |
| ADAR1 Capital Management, LLC | $561.884 | 20.447 | 0,12% | Azioni |
| Palumbo Wealth Management LLC | $545.891 | 19.865 | 0,11% | Azioni |
| CITADEL ADVISORS LLC | $508.380 | 18.500 | 0,11% | Opzione Call |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $502.884 | 18.300 | 0,10% | Opzione Put |
| TWO SIGMA INVESTMENTS, LP | $490.738 | 17.858 | 0,10% | Azioni |
| Engineers Gate Manager LP | $488.210 | 17.766 | 0,10% | Azioni |
| Eversept Partners, LP | $453.695 | 16.510 | 0,09% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $415.745 | 15.129 | 0,09% | Azioni |
| Cubist Systematic Strategies, LLC | $413.716 | 16.161 | 0,09% | Azioni |
| Virtus Investment Advisers, LLC | $391.617 | 14.251 | 0,08% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $363.808 | 13.239 | 0,08% | Azioni |
| RHUMBLINE ADVISERS | $318.486 | 11.590 | 0,07% | Azioni |
| Integrated Quantitative Investments LLC | $276.943 | 10.078 | 0,06% | Azioni |
| CITADEL ADVISORS LLC | $271.942 | 9.896 | 0,06% | Azioni |
| DEUTSCHE BANK AG\ | $264.220 | 9.615 | 0,05% | Azioni |
| BANK OF AMERICA CORP /DE/ | $262.901 | 9.567 | 0,05% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $239.076 | 8.700 | 0,05% | Opzione Call |
| Bank of New York Mellon Corp | $234.075 | 8.518 | 0,05% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $233.580 | 8.500 | 0,05% | Azioni |
| EntryPoint Capital, LLC | $227.672 | 8.285 | 0,05% | Azioni |
| WELLS FARGO & COMPANY/MN | $226.792 | 8.253 | 0,05% | Azioni |
| Brevan Howard Capital Management LP | $213.382 | 7.765 | 0,04% | Azioni |
| Persistent Asset Partners Ltd | $190.766 | 6.942 | 0,04% | Azioni |
| MetLife Investment Management, LLC | $161.720 | 5.885 | 0,03% | Azioni |
| BARCLAYS PLC | $140.314 | 5.106 | 0,03% | Azioni |
| Vanguard Global Advisers, LLC | $126.820 | 4.615 | 0,03% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $124.182 | 4.519 | 0,03% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $115.416 | 4.200 | 0,02% | Azioni |
| MARSHALL WACE, LLP | $111.184 | 4.046 | 0,02% | Azioni |
| CITIGROUP INC | $109.508 | 3.985 | 0,02% | Azioni |
| Invesco Ltd. | $107.969 | 3.929 | 0,02% | Azioni |
| Nuveen, LLC | $100.824 | 3.669 | 0,02% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $79.884 | 2.907 | 0,02% | Azioni |
| NORTHERN TRUST CORP | $42.512 | 1.547 | 0,01% | Azioni |
| Legal & General Group Plc | $26.326 | 958 | 0,01% | Azioni |
| Ameritas Investment Partners, Inc. | $24.595 | 895 | 0,01% | Azioni |
| Russell Investments Group, Ltd. | $21.654 | 788 | 0,00% | Azioni |
| HSBC HOLDINGS PLC | $17.104 | 16.935 | 0,00% | Azioni |
| Tower Research Capital LLC (TRC) | $14.564 | 530 | 0,00% | Azioni |
| ROYAL BANK OF CANADA | $12.000 | 440 | 0,00% | Azioni |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7.145 | 260 | 0,00% | Azioni |
| Accent Capital Management, LLC | $5.826 | 212 | 0,00% | Azioni |
| Sterling Capital Management LLC | $5.469 | 199 | 0,00% | Azioni |
| Truvestments Capital LLC | $5.304 | 193 | 0,00% | Azioni |
| FMR LLC | $4.891 | 178 | 0,00% | Azioni |
| Integrated Wealth Concepts LLC | $2.968 | 108 | 0,00% | Azioni |
| OSAIC HOLDINGS, INC. | $2.748 | 100 | 0,00% | Azioni |
| Quarry LP | $2.061 | 75 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $2.061 | 75 | 0,00% | Azioni |
| EverSource Wealth Advisors, LLC | $1.511 | 55 | 0,00% | Azioni |
| GSA CAPITAL PARTNERS LLP | $1.180 | 42.931 | 0,00% | Azioni |
| UBS Group AG | $550 | 20 | 0,00% | Azioni |
| Point72 Europe (London) LLP | $332 | 13 | 0,00% | Azioni |
| Allworth Financial LP | $275 | 10 | 0,00% | Azioni |
| PRICE T ROWE ASSOCIATES INC /MD/ | $226 | 8.203 | 0,00% | Azioni |
Insider aziendali 34 insider · 14 dirigenti · 16 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jason A Okazaki | CEO and President | 29 Marzo 2026 A | 163.354 | 0 | 0 | $0 |
| Samar Michael P. | Chief Financial Officer | 25 Luglio 2022 S | 77.228 | 0 | 0 | $0 |
| Thomas Joseph Russo | CFO | 29 Marzo 2021 A | 54.633 | 0 | 0 | $0 |
| Graham K Cooper | Chief Financial Officer and Chief Operating Officer | 29 Marzo 2019 A | 117.500 | 0 | 0 | $0 |
| Jeanette M Bjorkquist | PFO and PAO | 17 Giugno 2026 S | 14.560 | 0 | 3 | $-9.429 |
| Anuj Gaggar | Chief Medical Officer | 29 Marzo 2026 A | 42.688 | 0 | 0 | $0 |
| Nicole S White | Chief Manufacturing Officer | 29 Marzo 2026 A | 48.145 | 0 | 2 | $-5.257 |
| William E Delaney IV | Chief Scientific Officer | 29 Marzo 2026 A | 60.330 | 0 | 0 | $0 |
| Luisa M Stamm | Chief Medical Officer | 29 Marzo 2022 A | 40.315 | 0 | 0 | $0 |
| Jacqueline Sybil Papkoff | SVP-CSO Microbiome | 14 Dicembre 2020 S | 37.364 | 0 | 0 | $0 |
| Richard James Colonno | EVP & CSO, Virology Ops | 27 Marzo 2020 A | 137.009 | 0 | 0 | $0 |
| Uri A Lopatin | Chief Medical Officer | 29 Marzo 2019 A | 627.361 | 0 | 0 | $0 |
| Thomas E Rollins | Chief Development Officer | 29 Marzo 2018 A | 3.750 | 0 | 0 | $0 |
| Thomas Andrew Rowland | Chief Business Officer | 15 Gennaio 2012 A | — | 0 | 0 | $0 |
| Michael Houghton | Direttore | 04 Giugno 2026 A | 3.202 | 0 | 0 | $0 |
| Lisa Johnson-Pratt | Direttore | 04 Giugno 2026 A | — | 0 | 0 | $0 |
| John G Mchutchison | Direttore | 04 Giugno 2026 A | 18.347 | 0 | 0 | $0 |
| Gina Consylman | Direttore | 04 Giugno 2026 A | — | 0 | 0 | $0 |
| Susan Mahony | Direttore | 04 Giugno 2026 A | — | 0 | 0 | $0 |
| Anthony E Altig | Direttore | 04 Giugno 2026 A | 40.000 | 0 | 0 | $0 |
| William R Ringo | Direttore | 05 Giugno 2025 A | 17.465 | 0 | 0 | $0 |
| Richard D Dimarchi | Direttore | 25 Maggio 2022 A | — | 0 | 0 | $0 |
| Myron Z Holubiak | Direttore | 20 Maggio 2021 A | — | 0 | 0 | $0 |
| Helen Kim | Direttore | 11 Giugno 2020 A | — | 0 | 0 | $0 |
| Alan Lewis | Direttore | 11 Giugno 2020 A | — | 0 | 0 | $0 |
| Derek A Small | Direttore | 02 Gennaio 2020 A | 828.791 | 0 | 0 | $0 |
| Mark Auerbach | Direttore | 17 Maggio 2019 A | — | 0 | 0 | $0 |
| Russell H Ellison | Direttore | 10 Luglio 2014 A | 21.600 | 0 | 0 | $0 |
| Joseph Felder | Direttore | 06 Marzo 2013 A | — | 0 | 0 | $0 |
| Gilead Sciences, Inc. | Proprietario del 10% | 08 Agosto 2025 P | 4.505.391 | 0 | 0 | $0 |
| Alexander Schornstein | Proprietario del 10% | 25 Novembre 2024 P | 728.113 | 0 | 0 | $0 |
| EcoR1 Capital Fund Qualified, L.P. | Proprietario del 10% | 17 Aprile 2018 P | — | 0 | 0 | $0 |
| Adam Zlotnick | Proprietario del 10% | 10 Luglio 2014 A | — | 0 | 0 | $0 |
| David Jonathan Barrett | — | 29 Marzo 2017 A | 19.396 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. ×5 depositi | 27 Maggio 2026 | 25,10% | Modifica | — | SEC |
| Alexander Schornstein ×3 depositi | 24 Giugno 2024 | — | Deposito iniziale | — | SEC |
| 31 Ottobre 2023 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 12 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,55% | 7.645 NS | 30 Aprile 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 33.699 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8.569 SH | 08 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | 0,02% | 88.387 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 56.627 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 9.650 NS | 31 Maggio 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 240.066 SH | 08 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 6.713 SH | 08 Agosto 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 133.234 SH | 08 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 413.284 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 885 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 25.072 SH | 08 Agosto 2026 | Giornaliero |